BIH @en

Jennifer Kirwan named head of the BIH Metabolomics Core Facility

Mass spectrometry metabolomics at the MDC now has a second leg to stand on: On October 1, Dr. Jennifer Kirwan took up her position as the new head of the Metabolomics Core Facility of the Berlin Institute of Health (BIH), which is situated at the MDC. Dr. Stefan Kempa, who has been in charge until now, will continue to head the Metabolomics Core Facility within BIMSB.

Personalized medicine: T cells fight cancer

In cancer, one of the body’s cells stops playing by the rules that govern the cell cycle and divides uncontrollably. This is often due to mutations that lead to errors in the mechanisms that control cell division. Several teams of scientists at the MDC and the Charité are working on a T-cell therapy that specifically […]

A single roof at Berlin-Buch for scientists, doctors and patients

A joint press release by the Max Delbrück Center for Molecular Medicine (MDC), Charité – Universitätsmedizin Berlin, and the Berlin Institute of Health (BIH) From 2017, a new building will be constructed on the Berlin-Buch research campus that will unite several institutions under one roof. The Max Delbrück Center for Molecular Medicine (MDC) and Charité […]

Gene therapy: T cells target mutations to fight tumors

An international research team from the Max Delbrück Center for Molecular Medicine (MDC) and the Charité (partners in the Berlin Institute of Health, BIH), the Humboldt University Berlin and the University of Chicago has successfully modified immune cells to recognize and specifically target tumor cells in mice. Cancer treatments based on the findings would likely […]